US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

  • 0.838
  • -0.052-5.83%
Trading 02/26 10:03 ET
2.48MMarket Cap0.11P/E (TTM)

About Agile Therapeutics Company

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

Company Profile

Company NameAgile Therapeutics
Listing Date05/23/2014
Issue Price6.00
CEOMr. Alfred F. Altomari
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address500 College Road East,Suite 310
ProvinceNew Jersey
CountryUnited States of America
Zip Code08540-1715

Company Executives

  • Name
  • Position
  • Salary
  • Alfred F. Altomari
  • Chairman of the Board and Chief Executive Officer
  • 2.41M
  • Geoffrey P. Gilmore,J.D.
  • Senior Vice President Chief Administrative Officer
  • 1.16M
  • Scott M. Coiante
  • Senior Vice President, Chief Financial Officer and Treasurer
  • --
  • Paul Korner
  • Senior Vice President and Chief Medical Officer
  • 975.09K
  • Robert G. Conway
  • Senior Vice President and Chief Corporate Planning and Supply Chain Officer
  • --
  • Amy Welsh
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. John W. Hubbard
  • Independent Director
  • 140.00K
  • Sharon Surrey-Barbari
  • Independent Director
  • 145.00K
  • Seth H.Z. Fischer
  • Lead Independent Director
  • 170.00K
  • Dr. Sandra Carson, M.D.
  • Independent Director
  • 130.00K
  • Josephine Torrente
  • Independent Director
  • 150.00K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price